Changing Paradigms in the Treatment of Advanced Urothelial Carcinoma: A 2020 Update

Changing Paradigms in the Treatment of Advanced Urothelial Carcinoma: A 2020 Update

Advanced urothelial cancer (aUC) is invariably lethal and standard of care, platinum-based chemotherapy has changed little over the past 25 years. However, the past 5 years have been transformational with the advent of immunotherapies and targeted therapies. In this review, the authors focus on the...

Full description

Bibliographic Details
Main Authors: Alvin Jun Xing Lee, Jasmin Viktoria Waterhouse, Mark Linch
Format: Article
Language:English
Published: European Medical Journal 2020-12-01
Series:European Medical Journal
Subjects:
antibody-drug conjugates (adc)
bispecific antibodies
bladder cancer
enfortumab vedotin (ev)
fibroblast growth factor receptor (fgfr)
immunotherapy
nectin-4
targeted therapies
urothelial cancer
Online Access:https://www.emjreviews.com/oncology/article/changing-paradigms-in-the-treatment-of-advanced-urothelial-carcinoma-a-2020-update/

Internet

https://www.emjreviews.com/oncology/article/changing-paradigms-in-the-treatment-of-advanced-urothelial-carcinoma-a-2020-update/

Similar Items